Please try another search
For the nine months ended 30 September 2017, SpectraScience Inc revenues decreased from $5K to $0K. Net loss increased 30% to $3.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Change in fair value of derivative and w increase from $419K to $879K (expense), Interest expense increase of 41% to $1.1M (expense).
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | -0.2 | |
Operating Income | -0.17 | -0.35 | -0.84 | -0.98 |
Net Income | -1.55 | -1.25 | -1 | -1.54 |
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Assets | 1.22 | 1.23 | 1.41 | 1.39 |
Total Liabilities | 14.22 | 13.36 | 12.42 | 11.9 |
Total Equity | -13 | -12.13 | -11.01 | -10.52 |
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.49 | -0.39 | -0.19 | -1.51 |
Cash From Investing Activities | 0 | 0 | 0 | 0 |
Cash From Financing Activities | 0.51 | 0.39 | 0.29 | 1.39 |
Net Change in Cash | 0.02 | -0 | 0.1 | -0.12 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review